Search the Newsreel

USAR Stock Alert: What to Know as USA Rare Earth Announces Leadership Transition

A concept image showing a periodic table for rare earth metals by William Potter via Shutterstock Mining company USA Rare Earth (USAR) has named Serra Verde CEO Thras Moraitis as its next CEO after Barbara Humpton retires. Humpton has been instrumental in the company …

Lynas Rare Earths: June quarter earnings break records

Why Lynas shares tumbled 9% despite record rare earth prices

Lynas Rare Earths Limited (ASX: LYC): Record Revenue Fails to Prevent Share Price Decline

Tactical Resources Wins Nasdaq Approval Ahead of SPAC Deal Closing

By Jarrett Banks Tactical Resources Corp. (TSXV: RARE; OTC: USREF) said it received Nasdaq approval to list shares of the company formed through its business combination with Plum Acquisition Corp. III (OTC: PLMJF). The transaction is expected to close on July 28, after which …

Ultragenyx Pharmaceutical Stock Slides 20% With A 9-Day Losing Spree

Ultragenyx Pharmaceutical stock has experienced a significant downturn, sliding 20% over a nine-day losing streak. The article headline indicates this substantial drop in share value for the pharmaceutical company. Limited content provided, so specific causes are not detailed.

Ultragenyx Pharmaceutical Stock Extends A 9-Day Losing Streak To A 20% Loss

Ultragenyx Pharmaceutical (RARE) stock has experienced a 9-day losing streak, resulting in a 20.5% loss and a $738 million reduction in market value. This decline brings the company's market value to $2.9 billion. The market is scrutinizing the biotech firm's financial performance, noting its …

Earnings call transcript: Lynas Rare Earths posts record pricing in Q4 2026 as stock falls

RARE stock reflects Ultragenyx cash position and recent clinical progress

The article discusses how Ultragenyx Pharmaceutical's (RARE stock) valuation is influenced by its cash reserves, ongoing clinical progress in rare diseases, and commercialization efforts. It highlights the balance between strong cash positions and recurring operating losses typical of biotech companies, emphasizing the importance of …

(RARE) Movement as an Input in Quant Signal Sets

This article from Stock Traders Daily analyzes Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), highlighting a prevailing weak sentiment and an exceptional 68.4:1 risk-reward short setup. It details three AI-generated institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, alongside …

Malaysia Reviews Lynas' Pentagon Rare Earth Deal, Policy Response Due in Two Weeks

This article first appeared on GuruFocus. Lynas Rare Earths, a Perth-based rare-earth producer with a mine and processing plant in Western Australia and a facility in Malaysia, is facing growing political scrutiny over its agreement to supply rare-earth materials to the United States. A …

USA Rare Earth Names Serra Verde CEO as Barbara Humpton Steps Down

USA Rare Earth has named Serra Verde CEO Thras Moraitis as its next chief executive officer, signaling a leadership shift as the company moves toward completing its planned merger with the Brazilian rare earth producer and focuses on operational execution. Moraitis will assume the …

Tactical Resources and Plum Acquisition Corp. III Announce Receipt of Nasdaq Approval; Transaction Expected to Close on July 28, 2026

Resulting Issuer to Trade on Nasdaq under Ticker Symbol "TREO" VANCOUVER, British Columbia, July 20, 2026--(BUSINESS WIRE)--Tactical Resources Corp. (TSXV:RARE) (OTC:USREF) ("Tactical" or the "Company"), a U.S.-focused rare earth elements development company, today announced that it has received an approval letter from the Nasdaq …

RARE - burns cash despite four approved drugs, trapped by structural inefficiencies and gene-therapy scaling hurdles that thin safety margins.

Ultragenyx Pharmaceutical (RARE) is burning cash despite having four approved rare-disease drugs, due to structural inefficiencies and challenges in scaling gene-therapy manufacturing. The author argues that the company's commercial model is inefficient, its royalty streams are diluted, and current restructuring efforts are defensive rather …

Ultragenyx Pharmaceutical (RARE) On Rare Disease Growth Narrative And Why Valuation Is Back In Focus

Ultragenyx Pharmaceutical (RARE) stock is experiencing a valuation reassessment, with its rare disease portfolio and late-stage pipeline driving investor focus. While a narrative suggests the stock is 43.7% undervalued at $52.05 against its current $29.28 price, based on strong growth potential in rare disease …

Ultragenyx Pharmaceutical Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since December 2024 -- Data Talk

Ultragenyx Pharmaceutical (RARE) is experiencing its longest losing streak since December 2024, having been down for eight consecutive trading days. This represents a significant decline for the company, as indicated by its stock performance and comparison to past trends.

RARE stock rises after Ultragenyx reports strong Crysvita revenue growth and narrows quarterly loss

Ultragenyx Pharmaceutical Inc. (RARE) stock saw a rise following reports of strong Crysvita revenue growth and a narrowed net loss in its latest quarterly update. Crysvita, a key therapy for rare metabolic bone conditions, has been a significant driver of the company's product revenue, …

Texas Mineral Resources and USA Rare Earth Merger Sparks Stockholder Lawsuits and Leads to Supplemental Disclosure

Texas Mineral Resources Corp. and USA Rare Earth, Inc. have issued supplemental disclosure materials after two stockholder lawsuits and multiple demand letters challenged their planned merger, announced on March 4, 2026. The new filings aim to provide additional information to stockholders, including prospective financial …

Australian Rare Earths (ASX:AR3) Gains After Identifying New Niobium-Rare Earth Exploration Target

Arafura Rare Earths (ASX:ARU) After Its Supply Deal And Funding Progress, Is It Undervalued

Price to earnings forward of Rainbow Rare Earths Ltd. – LSE:RBW

Why is JL Mag Rare-Earth stock surging today?

Hong Kong Stock Market Movement | JL MAG Rare-Earth Permanent Magnet (06680.HK) Rises Over 11% as H1 Net Profit Forecast Shows Up to 50.84% Year-on-Year Increase

New Indian Offtake Deal And Nolans Build-Out Might Change The Case For Investing In Arafura Rare Earths (ASX:ARU)

Arafura Rare Earths (ASX:ARU) Back on Watchlists as Critical Minerals Interest Returns

Arafura Rare Earths Limited Actuals & Estimates (ASX:ARU)

RARE Forecast — Price Target — Prediction for 2027

Is Australian Rare Earths (ASX: AR3) About to Become Australia's Most Important Rare Earth Story?

Arafura Rare Earths (ASX:ARU) Falls Today as Critical Minerals Trade Cools

Lynas Rare Earths (ASX:LYC): The Rare Earths Stock Back in the Spotlight

Arafura Rare Earths (ASX:AR3) Draws Fresh Market Attention

Lynas Rare Earths (ASX:LYC) Shares After Strong Yearly Gains Is There Still Upside Potential

USA Rare Earth Secures $1.6B to Advance Rare Earth Value Chain

Altona Rare Earths Identifies Significant Heavy Rare Earth Potential at Monte Muambe Project (REE)

Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound?

JL MAG Rare-Earth Announces Resignation of Independent Director Xu Feng